Biopharma Sales Compensation Plan Diagnostic
What is the SCOR³ES® Diagnostic?
Developed over 20 years ago exclusively for the pharma, biotech and medical device industries, SCOR³ES® is a biopharma sales incentive compensation diagnostic that quantifies the performance of sales incentive compensation plans against the six critical criteria of plan effectiveness, including four patent-pending tests of equity.
SCOR³ES®’s Correlation With Sales
What makes SCOR³ES® so powerful is that over the years, the SCOR³ES® rating system has been fine-tuned such that improvements in SCOR³ES® ratings have been statistically shown to be correlated with increases in sales, demonstrating that replacing a poor sales incentive compensation plan with a good one can increase sales anywhere from 7%-18%.
What SCOR³ES® Can Do For You
SCOR³ES® can provide invaluable insight to you both during the design stage as well as after the plan period has ended. Below are just some of the things our SCOR³ES® pharma sales compensation plan evaluation can do for you.
Clients We’ve Served
Join the companies that have revolutionized their sales compensation and sales optimization strategy with The Marketing Advantage, from small start-ups to multi-national corporations.
Learn More About Our Sales Compensation Solutions
Goal Setting
See how we maximize goal accuracy through customizing goal setting to each client’s unique needs and conditions.
Launch Sales Compensation
Achieve fast adoption and secure your new product’s position in the marketplace with our proven launch sales compensation strategies.
Rare Disease Sales Compensation
We design sales compensation plans for rare disease products that maximize the product’s ability to reach as many patients as possible.